^
BIOMARKER:

PIK3CG mutation

i
Other names: PIK3CG, Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Gamma, Phosphatidylinositol 4,5-Bisphosphate 3-Kinase Catalytic Subunit Gamma Isoform, Serine/Threonine Protein Kinase PIK3CG, PtdIns-3-Kinase Subunit P110-Gamma, PtdIns-3-Kinase Subunit Gamma, PI3-Kinase Subunit Gamma, PI3Kgamma, P110gamma, P120-PI3K, Phosphatidylinositol-4 5-Bisphosphate 3-Kinase 110 KDa Catalytic Subunit Gamma, Phosphatidylinositol-4 5-Bisphosphate 3-Kinase Catalytic Subunit Gamma Isoform, Phosphatidylinositol 4 5-Bisphosphate 3-Kinase 110 KDa Catalytic Subunit Gamma, Phosphatidylinositol-4 5-Bisphosphate 3-Kinase Catalytic Subunit Gamma 2, Phosphoinositide-3-Kinase Catalytic Gamma Polypeptide, Phosphoinositide-3-Kinase Catalytic Gamma Polypeptide, Phosphatidylinositol 3-Kinase Catalytic 110-KD Gamma, Phosphoinositide-3-Kinase Gamma Catalytic Subunit, Phosphatidylinositol 3 Kinase Gamma P110 Gamma, 1-Phosphatidylinositol 3-Kinase, PI3K-Gamma, PI3CG, PI3K, PIK3
Entrez ID:
Related biomarkers:
News
Twitter
Trials
PIK3CG mutation
NSCLC
nivolumab + ipilimumab
Sensitive: C3 – Early Trials
PIK3CG mutation
Melanoma
Immunotherapy
Sensitive: C3 – Early Trials